{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:29:24Z","timestamp":1770071364487,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04499-y","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:04:21Z","timestamp":1770030261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of gender affirming hormone therapy on bone mineral density and bone marrow composition in transgender adults"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6291-1887","authenticated-orcid":false,"given":"Silvia","family":"Di Chiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9294-5455","authenticated-orcid":false,"given":"Davide","family":"Diacinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-1202","authenticated-orcid":false,"given":"Cristiana","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6894-3433","authenticated-orcid":false,"given":"Daniele","family":"Diacinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4866-7130","authenticated-orcid":false,"given":"Enrico Delli","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1566-6553","authenticated-orcid":false,"given":"Jessica","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-6474","authenticated-orcid":false,"given":"Francesco","family":"Pallotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"4","key":"4499_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1177\/0141076817696054","volume":"110","author":"A Joseph","year":"2017","unstructured":"A. Joseph, C. Cliffe, M. Hillyard, A. Majeed, Gender identity and the management of the transgender patient: a guide for non-specialists. J. R Soc. Med. 110(4), 144\u2013152 (2017). https:\/\/doi.org\/10.1177\/0141076817696054","journal-title":"J. R Soc. Med."},{"issue":"Suppl 1","key":"4499_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","volume":"23","author":"E Coleman","year":"2022","unstructured":"E. Coleman, A.E. Radix, W.P. Bouman, G.R. Brown, de A.L.C. Vries, M.B. Deutsch et al., Standards of care for the health of transgender and gender diverse People, version 8. Int. J. Transgend Health. 23(Suppl 1), S1\u2013S259 (2022). https:\/\/doi.org\/10.1080\/26895269.2022.2100644","journal-title":"Int. J. Transgend Health"},{"issue":"3","key":"4499_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40618-021-01694-2","volume":"45","author":"AD Fisher","year":"2022","unstructured":"A.D. Fisher, G. Senofonte, C. Cocchetti, G. Guercio, V. Lingiardi, M.C. Meriggiola et al., SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people. J. Endocrinol. Invest. 45(3), 657\u2013673 (2022). https:\/\/doi.org\/10.1007\/s40618-021-01694-2","journal-title":"J. Endocrinol. Invest."},{"issue":"11","key":"4499_CR4","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1210\/jc.2016-1276","volume":"101","author":"AD Fisher","year":"2016","unstructured":"A.D. Fisher, G. Castellini, J. Ristori, H. Casale, E. Cassioli, C. Sensi et al., Cross-Sex hormone treatment and Psychobiological changes in transsexual persons: Two-Year Follow-Up data. J. Clin. Endocrinol. Metab. 101(11), 4260\u20134269 (2016). https:\/\/doi.org\/10.1210\/jc.2016-1276","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4499_CR5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12020-023-03421-8","volume":"81","author":"F Pallotti","year":"2023","unstructured":"F. Pallotti, G. Senofonte, A.C. Conflitti, A. Giancotti, A. Anzuini, E. Delli Paoli et al., Safety of gender affirming treatment in assigned female at birth transgender people and association of androgen and Estrogen beta receptor polymorphisms with clinical outcomes. Endocrine. 81(3), 621\u2013630 (2023). https:\/\/doi.org\/10.1007\/s12020-023-03421-8","journal-title":"Endocrine"},{"issue":"11","key":"4499_CR6","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","volume":"102","author":"WC Hembree","year":"2017","unstructured":"W.C. Hembree, P.T. Cohen-Kettenis, L. Gooren, S.E. Hannema, W.J. Meyer, M.H. Murad et al., Endocrine treatment of Gender-Dysphoric\/Gender-Incongruent persons: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 102(11), 3869\u20133903 (2017). https:\/\/doi.org\/10.1210\/jc.2017-01658","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"4499_CR7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jsxm.2020.01.012","volume":"17","author":"G T\u2019Sjoen","year":"2020","unstructured":"G. T\u2019Sjoen, J. Arcelus, De A.L.C. Vries, A.D. Fisher, T.O. Nieder, M. Ozer et al., European society for sexual medicine position statement assessment and hormonal management in adolescent and adult trans People, with attention for sexual function and satisfaction. J. Sex. Med. 17(4), 570\u2013584 (2020). https:\/\/doi.org\/10.1016\/j.jsxm.2020.01.012","journal-title":"J. Sex. Med."},{"issue":"12 Suppl","key":"4499_CR8","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1002\/1097-0142(19931215)72:12+<3810::aid-cncr2820721710>3.0.co;2-o","volume":"72","author":"FH Schroder","year":"1993","unstructured":"F.H. Schroder, Cyproterone acetate\u2013mechanism of action and clinical effectiveness in prostate cancer treatment. Cancer. 72(12 Suppl), 3810\u20133815 (1993). https:\/\/doi.org\/10.1002\/1097-0142(19931215)72:12+%3C3810::aid-cncr2820721710%3E3.0.co;2-o","journal-title":"Cancer"},{"issue":"6","key":"4499_CR9","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1210\/en.2006-1469","volume":"148","author":"TV Nguyen","year":"2007","unstructured":"T.V. Nguyen, M. Yao, C.J. Pike, Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection. Endocrinology. 148(6), 2936\u20132943 (2007). https:\/\/doi.org\/10.1210\/en.2006-1469","journal-title":"Endocrinology"},{"key":"4499_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.maturitas.2019.05.002","volume":"127","author":"C Davidge-Pitts","year":"2019","unstructured":"C. Davidge-Pitts, B.L. Clarke, Transgender bone health. Maturitas. 127, 35\u201342 (2019). https:\/\/doi.org\/10.1016\/j.maturitas.2019.05.002","journal-title":"Maturitas"},{"issue":"6","key":"4499_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1210\/er.2014-1024","volume":"35","author":"D Vanderschueren","year":"2014","unstructured":"D. Vanderschueren, M.R. Laurent, F. Claessens, E. Gielen, M.K. Lagerquist, L. Vandenput et al., Sex steroid actions in male bone. Endocr. Rev. 35(6), 906\u2013960 (2014). https:\/\/doi.org\/10.1210\/er.2014-1024","journal-title":"Endocr. Rev."},{"issue":"4","key":"4499_CR12","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1128\/MCB.01550-06","volume":"27","author":"S Kousteni","year":"2007","unstructured":"S. Kousteni, M. Almeida, L. Han, T. Bellido, R.L. Jilka, S.C. Manolagas, Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the Estrogen receptor. Mol. Cell. Biol. 27(4), 1516\u20131530 (2007). https:\/\/doi.org\/10.1128\/MCB.01550-06","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"4499_CR13","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/jbmr.3102","volume":"32","author":"CM Wiepjes","year":"2017","unstructured":"C.M. Wiepjes, M.C. Vlot, M. Klaver, N.M. Nota, de C.J. Blok, de R.T. Jongh et al., Bone mineral density increases in trans persons after 1 year of hormonal treatment: A multicenter prospective observational study. J. Bone Min. Res. 32(6), 1252\u20131260 (2017). https:\/\/doi.org\/10.1002\/jbmr.3102","journal-title":"J. Bone Min. Res."},{"issue":"2","key":"4499_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/EJE-14-0586","volume":"172","author":"E Van Caenegem","year":"2015","unstructured":"Van E. Caenegem, K. Wierckx, Y. Taes, T. Schreiner, S. Vandewalle, K. Toye et al., Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI). Eur. J. Endocrinol. 172(2), 163\u2013171 (2015). https:\/\/doi.org\/10.1530\/EJE-14-0586","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"4499_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12018-019-09261-3","volume":"17","author":"MS Rothman","year":"2019","unstructured":"M.S. Rothman, S.J. Iwamoto, Bone health in the transgender population. Clin. Rev. Bone Min. Metab. 17(2), 77\u201385 (2019). https:\/\/doi.org\/10.1007\/s12018-019-09261-3","journal-title":"Clin. Rev. Bone Min. Metab."},{"issue":"5","key":"4499_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00223-012-9643-0","volume":"91","author":"D Diacinti","year":"2012","unstructured":"D. Diacinti, Del R. Fiacco, D. Pisani, F. Todde, M.S. Cattaruzza, D. Diacinti et al., Diagnostic performance of vertebral fracture assessment by the lunar iDXA scanner compared to conventional radiography. Calcif Tissue Int. 91(5), 335\u2013342 (2012). https:\/\/doi.org\/10.1007\/s00223-012-9643-0","journal-title":"Calcif Tissue Int."},{"key":"4499_CR17","doi-asserted-by":"publisher","first-page":"115608","DOI":"10.1016\/j.bone.2020.115608","volume":"143","author":"D Diacinti","year":"2021","unstructured":"D. Diacinti, D. Pisani, C. Cipriani, M. Celli, A. Zambrano, D. Diacinti et al., Vertebral fracture assessment (VFA) for monitoring vertebral reshaping in children and adolescents with osteogenesis imperfecta treated with intravenous neridronate. Bone. 143, 115608 (2021). https:\/\/doi.org\/10.1016\/j.bone.2020.115608","journal-title":"Bone"},{"key":"4499_CR18","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1210\/clinem\/dgab076","volume":"106","author":"CMS Cipriani","year":"2021","unstructured":"C.M.S. Cipriani, J.P. Bilezikian, D. Diacinti, L. Colangelo, V. Piazzolla, M. Angelozzi, L. Nieddu, J. Pepe, D. Diacinti, Vertebral fracture assessment in postmenopausal women with postsurgical hypoparathyroidism. J. Clin. Endocrinol. Metab. 106, 1303\u20131311 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgab076","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"4499_CR19","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00198-023-06817-4","volume":"34","author":"E Shevroja","year":"2023","unstructured":"E. Shevroja, J.Y. Reginster, O. Lamy, N. Al-Daghri, M. Chandran, A.L. Demoux-Baiada et al., Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO), and the international osteoporosis foundation (IOF) under the auspices of WHO collaborating center for epidemiology of musculoskeletal health and aging. Osteoporos. Int. 34(9), 1501\u20131529 (2023). https:\/\/doi.org\/10.1007\/s00198-023-06817-4","journal-title":"Osteoporos. Int."},{"key":"4499_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02056-w","author":"LCC Cianferotti","year":"2023","unstructured":"L.C.C. Cianferotti, S. Corbetta, G. Corona, G. Defeudis, A.G. Lania, C. Messina, N. Napoli, G. Mazziotti, Bone quality in endocrine diseases: determinants and clinical relevance. J. Endocrinol. Invest. (2023). https:\/\/doi.org\/10.1007\/s40618-023-02056-w","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"4499_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/jbmr.4497","volume":"37","author":"I Bretherton","year":"2022","unstructured":"I. Bretherton, A. Ghasem-Zadeh, S.Y. Leemaqz, E. Seeman, X. Wang, T. McFarlane et al., Bone microarchitecture in transgender adults: A Cross-Sectional study. J. Bone Min. Res. 37(4), 643\u2013648 (2022). https:\/\/doi.org\/10.1002\/jbmr.4497","journal-title":"J. Bone Min. Res."},{"issue":"4","key":"4499_CR22","doi-asserted-by":"publisher","first-page":"R165","DOI":"10.1530\/EJE-18-0182","volume":"179","author":"T Rharass","year":"2018","unstructured":"T. Rharass, S. Lucas, MECHANISMS IN ENDOCRINOLOGY: bone marrow adiposity and bone, a bad romance? Eur. J. Endocrinol. 179(4), R165\u2013R82 (2018). https:\/\/doi.org\/10.1530\/EJE-18-0182","journal-title":"Eur. J. Endocrinol."},{"key":"4499_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fendo.2017.00112","volume":"8","author":"WP Cawthorn","year":"2017","unstructured":"W.P. Cawthorn, E.L. Scheller, Editorial, Bone marrow adipose tissue: Formation, Function, and impact on health and disease. Front. Endocrinol. (Lausanne). 8, 112 (2017). https:\/\/doi.org\/10.3389\/fendo.2017.00112","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"4499_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00223-016-0168-9","volume":"100","author":"CS Craft","year":"2017","unstructured":"C.S. Craft, E.L. Scheller, Evolution of the marrow adipose tissue microenvironment. Calcif Tissue Int. 100(5), 461\u2013475 (2017). https:\/\/doi.org\/10.1007\/s00223-016-0168-9","journal-title":"Calcif Tissue Int."},{"key":"4499_CR25","doi-asserted-by":"publisher","first-page":"981487","DOI":"10.3389\/fendo.2022.981487","volume":"13","author":"D Ali","year":"2022","unstructured":"D. Ali, M. Tencerova, F. Figeac, M. Kassem, A. Jafari, The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: the mechanisms and roles of increased bone marrow adiposity. Front. Endocrinol. (Lausanne). 13, 981487 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.981487","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"4499_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.6061\/clinics\/2016(08)09","volume":"71","author":"ML Mendonca","year":"2016","unstructured":"M.L. Mendonca, S.L. Batista, M.H. Nogueira-Barbosa, C.E. Salmon, F.J. Paula, Primary hyperparathyroidism: the influence of bone marrow adipose tissue on bone loss and of osteocalcin on insulin resistance. Clin. (Sao Paulo). 71(8), 464\u2013469 (2016). https:\/\/doi.org\/10.6061\/clinics\/2016(08)09","journal-title":"Clin. (Sao Paulo)"},{"issue":"6","key":"4499_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/cen.12367","volume":"80","author":"C McComb","year":"2014","unstructured":"C. McComb, A. Harpur, C. Yacoubian, C. Leddy, G. Anderson, S. Shepherd et al., MRI-based abnormalities in young adults at risk of adverse bone health due to childhood-onset metabolic & endocrine conditions. Clin. Endocrinol. (Oxf). 80(6), 811\u2013817 (2014). https:\/\/doi.org\/10.1111\/cen.12367","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"10","key":"4499_CR28","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s00198-015-3161-7","volume":"26","author":"A Cohen","year":"2015","unstructured":"A. Cohen, W. Shen, D.W. Dempster, H. Zhou, R.R. Recker, J.M. Lappe et al., Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by proton magnetic resonance spectroscopy ((1)H-MRS) at the spine but not the femur. Osteoporos. Int. 26(10), 2471\u20132478 (2015). https:\/\/doi.org\/10.1007\/s00198-015-3161-7","journal-title":"Osteoporos. Int."},{"key":"4499_CR29","doi-asserted-by":"publisher","unstructured":"J. Tratwal, R. Labella, N. Bravenboer, G. Kerckhofs, E. Douni, E.L. Scheller et al., Reporting Guidelines, review of methodological Standards, and challenges toward harmonization in bone marrow adiposity research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society. 2020 Front Endocrinol (Lausanne) 28: 11:65 https:\/\/doi.org\/10.3389\/fendo.2020.00065","DOI":"10.3389\/fendo.2020.00065"},{"key":"4499_CR30","doi-asserted-by":"publisher","first-page":"117307","DOI":"10.1016\/j.bone.2024.117307","volume":"190","author":"F Biamonte","year":"2025","unstructured":"F. Biamonte, J. Pepe, L. Colangelo, G. Desideri, E. Ettorre, L. Nieddu et al., Assessment of trabecular bone score (TBS) in the prediction of vertebral fracture in postmenopausal osteoporosis. Bone. 190, 117307 (2025). https:\/\/doi.org\/10.1016\/j.bone.2024.117307","journal-title":"Bone"},{"key":"4499_CR31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","volume":"78","author":"NC Harvey","year":"2015","unstructured":"N.C. Harvey, C.C. Gluer, N. Binkley, E.V. McCloskey, M.L. Brandi, C. Cooper et al., Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone. 78, 216\u2013224 (2015). https:\/\/doi.org\/10.1016\/j.bone.2015.05.016","journal-title":"Bone"},{"issue":"11","key":"4499_CR32","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00198-004-1626-1","volume":"15","author":"G Jiang","year":"2004","unstructured":"G. Jiang, R. Eastell, N.A. Barrington, L. Ferrar, Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis. Osteoporos. Int. 15(11), 887\u2013896 (2004). https:\/\/doi.org\/10.1007\/s00198-004-1626-1","journal-title":"Osteoporos. Int."},{"issue":"9","key":"4499_CR33","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.21037\/jtd-20-2379","volume":"12","author":"YXJ Wang","year":"2020","unstructured":"Y.X.J. Wang, W.H. Liu, D. Diacinti, D.W. Yang, A. Iannacone, X.R. Wang et al., Diagnosis and grading of radiographic osteoporotic vertebral deformity by general radiologists after a brief self-learning period. J. Thorac. Dis. 12(9), 4702\u20134710 (2020). https:\/\/doi.org\/10.21037\/jtd-20-2379","journal-title":"J. Thorac. Dis."},{"key":"4499_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-024-04678-4","author":"YXJ Wang","year":"2024","unstructured":"Y.X.J. Wang, D. Diacinti, M.P. Aparisi Gomez, F.R. Santiago, F. Becce, A.S. Tagliafico et al., Radiological diagnosis of prevalent osteoporotic vertebral fracture on radiographs: an interim consensus from a group of experts of the ESSR osteoporosis and metabolism subcommittee. Skeletal Radiol. (2024). https:\/\/doi.org\/10.1007\/s00256-024-04678-4","journal-title":"Skeletal Radiol."},{"issue":"9","key":"4499_CR35","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"H.K. Genant, C.Y. Wu, van C. Kuijk, M.C. Nevitt, Vertebral fracture assessment using a semiquantitative technique. J. Bone Min. Res. 8(9), 1137\u20131148 (1993). https:\/\/doi.org\/10.1002\/jbmr.5650080915","journal-title":"J. Bone Min. Res."},{"issue":"9","key":"4499_CR36","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1210\/clinem\/dgad116","volume":"108","author":"D Diacinti","year":"2023","unstructured":"D. Diacinti, D.I.A. Diacinti, A. Pepe, L. Colangelo, L. Nieddu, E. Kripa, M. Orlandi, De V. Martino, S. Minisola, C. Cipriani, Bone marrow adipose tissue is increased in postmenopausal women with postsurgical hypoparathyroidism. J. Clin. Endocrinol. Metab. 108(9), e807\u2013e15 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgad116","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4499_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/jbmr.3612","volume":"34","author":"CM Wiepjes","year":"2019","unstructured":"C.M. Wiepjes, de R.T. Jongh, de C.J. Blok, M.C. Vlot, P. Lips, J.W. Twisk et al., Bone safety during the first ten years of Gender-Affirming hormonal treatment in transwomen and transmen. J. Bone Min. Res. 34(3), 447\u2013454 (2019). https:\/\/doi.org\/10.1002\/jbmr.3612","journal-title":"J. Bone Min. Res."},{"issue":"1","key":"4499_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bone.2013.01.039","volume":"54","author":"E Van Caenegem","year":"2013","unstructured":"Van E. Caenegem, Y. Taes, K. Wierckx, S. Vandewalle, K. Toye, J.M. Kaufman et al., Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy. Bone. 54(1), 92\u201397 (2013). https:\/\/doi.org\/10.1016\/j.bone.2013.01.039","journal-title":"Bone"},{"key":"4499_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bone.2019.06.029","volume":"127","author":"CM Wiepjes","year":"2019","unstructured":"C.M. Wiepjes, M.C. Vlot, de C.J.M. Blok, N.M. Nota, de R.T. Jongh, den M. Heijer, Bone geometry and trabecular bone score in transgender people before and after short- and long-term hormonal treatment. Bone. 127, 280\u2013286 (2019). https:\/\/doi.org\/10.1016\/j.bone.2019.06.029","journal-title":"Bone"},{"issue":"6","key":"4499_CR40","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.bone.2008.09.001","volume":"43","author":"B Lapauw","year":"2008","unstructured":"B. Lapauw, Y. Taes, S. Simoens, Van E. Caenegem, S. Weyers, S. Goemaere et al., Body composition, volumetric and areal bone parameters in male-to-female transsexual persons. Bone. 43(6), 1016\u20131021 (2008). https:\/\/doi.org\/10.1016\/j.bone.2008.09.001","journal-title":"Bone"},{"issue":"9","key":"4499_CR41","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.jsxm.2019.06.006","volume":"16","author":"M Dobrolinska","year":"2019","unstructured":"M. Dobrolinska, van der K. Tuuk, P. Vink, van den M. Berg, A. Schuringa, A.G. Monroy-Gonzalez et al., Bone mineral density in transgender individuals after gonadectomy and Long-Term Gender-Affirming hormonal treatment. J. Sex. Med. 16(9), 1469\u20131477 (2019). https:\/\/doi.org\/10.1016\/j.jsxm.2019.06.006","journal-title":"J. Sex. Med."},{"issue":"3","key":"4499_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1385\/jcd:6:3:297","volume":"6","author":"M Sosa","year":"2003","unstructured":"M. Sosa, E. Jodar, E. Arbelo, C. Dominguez, P. Saavedra, A. Torres et al., Bone mass, bone turnover, vitamin D, and Estrogen receptor gene polymorphisms in male to female transsexuals: effects of Estrogenic treatment on bone metabolism of the male. J. Clin. Densitom. 6(3), 297\u2013304 (2003). https:\/\/doi.org\/10.1385\/jcd:6:3:297","journal-title":"J. Clin. Densitom"},{"key":"4499_CR43","doi-asserted-by":"publisher","unstructured":"J.F. Chen, P.W. Lin, Y.R. Tsai, Y.C. Yang, H.Y. Kang, Androgens and androgen receptor actions on bone health and disease: from androgen deficiency to androgen therapy. Cells. 8(11) (2019). https:\/\/doi.org\/10.3390\/cells8111318","DOI":"10.3390\/cells8111318"},{"key":"4499_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/164_2019_327","volume":"262","author":"T Yoshida","year":"2020","unstructured":"T. Yoshida, J. Wang, P.H. Stern, Gonadal hormones and bone. Handb. Exp. Pharmacol. 262, 65\u201391 (2020). https:\/\/doi.org\/10.1007\/164_2019_327","journal-title":"Handb. Exp. Pharmacol."},{"issue":"12","key":"4499_CR45","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1210\/en.2015-1244","volume":"156","author":"A Di Nisio","year":"2015","unstructured":"Di A. Nisio, De L. Toni, E. Speltra, M.S. Rocca, G. Taglialavoro, A. Ferlin et al., Regulation of sclerostin production in human male osteocytes by androgens: experimental and clinical evidence. Endocrinology. 156(12), 4534\u20134544 (2015). https:\/\/doi.org\/10.1210\/en.2015-1244","journal-title":"Endocrinology"},{"issue":"3","key":"4499_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s0029-7844(01)01450-8","volume":"98","author":"T Douchi","year":"2001","unstructured":"T. Douchi, T. Oki, H. Yamasaki, R. Kuwahata, M. Nakae, Y. Nagata, Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstet. Gynecol. 98(3), 445\u2013449 (2001). https:\/\/doi.org\/10.1016\/s0029-7844(01)01450-8","journal-title":"Obstet. Gynecol."},{"key":"4499_CR47","doi-asserted-by":"publisher","first-page":"108951","DOI":"10.1016\/j.steroids.2021.108951","volume":"178","author":"SRL Andrade","year":"2022","unstructured":"S.R.L. Andrade, Y.M. Mucida, J.D.C. Xavier, L.N. Fernandes, R.O. Silva, F. Bandeira, Bone mineral density, trabecular bone score and muscle strength in transgender men receiving testosterone therapy versus cisgender men. Steroids. 178, 108951 (2022). https:\/\/doi.org\/10.1016\/j.steroids.2021.108951","journal-title":"Steroids"},{"issue":"12","key":"4499_CR48","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1210\/jc.2016-2695","volume":"101","author":"G Papadakis","year":"2016","unstructured":"G. Papadakis, D. Hans, E. Gonzalez-Rodriguez, P. Vollenweider, G. Waeber, P.M. Marques-Vidal et al., The benefit of menopausal hormone therapy on bone density and microarchitecture persists after its withdrawal. J. Clin. Endocrinol. Metab. 101(12), 5004\u20135011 (2016). https:\/\/doi.org\/10.1210\/jc.2016-2695","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4499_CR49","doi-asserted-by":"publisher","first-page":"100173","DOI":"10.1016\/j.metop.2022.100173","volume":"13","author":"N Chan Swe","year":"2022","unstructured":"N. Chan Swe, S. Ahmed, M. Eid, L. Poretsky, E. Gianos, N.E. Cusano, The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review. Metabol Open. 13, 100173 (2022). https:\/\/doi.org\/10.1016\/j.metop.2022.100173","journal-title":"Metabol Open."},{"key":"4499_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cytogfr.2020.02.003","volume":"52","author":"J Li","year":"2020","unstructured":"J. Li, X. Chen, L. Lu, X. Yu, The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis. Cytokine Growth Factor. Rev. 52, 88\u201398 (2020). https:\/\/doi.org\/10.1016\/j.cytogfr.2020.02.003","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"2","key":"4499_CR51","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12020-023-03318-6","volume":"80","author":"F Ferrau","year":"2023","unstructured":"F. Ferrau, S. Giovinazzo, Y. Alessi, A. Catalano, A. Tessitore, E. Mormina et al., Trabecular bone score, bone marrow fat and vertebral fractures in Cushing syndrome. Endocrine. 80(2), 441\u2013447 (2023). https:\/\/doi.org\/10.1007\/s12020-023-03318-6","journal-title":"Endocrine"},{"issue":"4","key":"4499_CR52","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jocd.2022.06.006","volume":"25","author":"N Nasomyont","year":"2022","unstructured":"N. Nasomyont, A.R. Meisman, K. Ecklund, S. Vajapeyam, K.M. Cecil, J.A. Tkach et al., Changes in bone marrow adipose tissue in transgender and gender Non-Conforming youth undergoing pubertal suppression: A pilot study. J. Clin. Densitom. 25(4), 485\u2013489 (2022). https:\/\/doi.org\/10.1016\/j.jocd.2022.06.006","journal-title":"J. Clin. Densitom"},{"key":"4499_CR53","doi-asserted-by":"publisher","first-page":"116454","DOI":"10.1016\/j.bone.2022.116454","volume":"162","author":"CE Guss","year":"2022","unstructured":"C.E. Guss, R. Eiduson, S. Vajapeyam, K. Ecklund, R. Mulkern, S.E. Dahlberg et al., Bone density and bone marrow composition in transgender girls prior to pubertal blockade: A case series. Bone. 162, 116454 (2022). https:\/\/doi.org\/10.1016\/j.bone.2022.116454","journal-title":"Bone"},{"issue":"3","key":"4499_CR54","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1148\/radiology.215.3.r00jn42910","volume":"215","author":"D Schellinger","year":"2000","unstructured":"D. Schellinger, C.S. Lin, D. Fertikh, J.S. Lee, W.C. Lauerman, F. Henderson et al., Normal lumbar vertebrae: anatomic, age, and sex variance in subjects at proton MR spectroscopy\u2013initial experience. Radiology. 215(3), 910\u2013916 (2000). https:\/\/doi.org\/10.1148\/radiology.215.3.r00jn42910","journal-title":"Radiology"},{"issue":"9","key":"4499_CR55","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00198-008-0574-6","volume":"19","author":"FA Syed","year":"2008","unstructured":"F.A. Syed, M.J. Oursler, T.E. Hefferanm, J.M. Peterson, B.L. Riggs, S. Khosla, Effects of Estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos. Int. 19(9), 1323\u20131330 (2008). https:\/\/doi.org\/10.1007\/s00198-008-0574-6","journal-title":"Osteoporos. Int."},{"issue":"10","key":"4499_CR56","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1210\/clinem\/dgad195","volume":"108","author":"J Paccou","year":"2023","unstructured":"J. Paccou, S. Badr, D. Lombardo, H. Khizindar, V. Deken, S. Ruschke et al., Bone marrow adiposity and fragility fractures in postmenopausal women: the ADIMOS Case-Control study. J. Clin. Endocrinol. Metab. 108(10), 2526\u20132536 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgad195","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4499_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bone.2016.12.018","volume":"97","author":"EW Yu","year":"2017","unstructured":"E.W. Yu, L. Greenblatt, A. Eajazi, M. Torriani, M.A. Bredella, Marrow adipose tissue composition in adults with morbid obesity. Bone. 97, 38\u201342 (2017). https:\/\/doi.org\/10.1016\/j.bone.2016.12.018","journal-title":"Bone"},{"key":"4499_CR58","doi-asserted-by":"publisher","first-page":"1168806","DOI":"10.3389\/fendo.2023.1168806","volume":"14","author":"L Xu","year":"2023","unstructured":"L. Xu, M. Min, X. Li, G.M. Blake, K. Zhao, X. Ruan et al., Marrow adipose tissue is increased in overweight and obese women with PCOS independently of hyperandrogenism related obesity and metabolic disorders. Front. Endocrinol. (Lausanne). 14, 1168806 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1168806","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4499_CR59","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf216","author":"M Zoulakis","year":"2025","unstructured":"M. Zoulakis, K.F. Axelsson, H. Litsne, L. Johansson, M. Lorentzon, Bone marrow adiposity assessed by HRpQCT is related to fracture risk and bone mineral density in older Swedish women. J. Clin. Endocrinol. Metab. (2025). https:\/\/doi.org\/10.1210\/clinem\/dgaf216","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4499_CR60","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.orcp.2018.06.006","volume":"12","author":"W Li","year":"2018","unstructured":"W. Li, C. Wang, M. Zhang, J. Wu, Y. Gu, Y. Deng et al., Young and old adipocytes have differential influence on the development of osteoblasts. Obes. Res. Clin. Pract. 12(6), 520\u2013527 (2018). https:\/\/doi.org\/10.1016\/j.orcp.2018.06.006","journal-title":"Obes. Res. Clin. Pract."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04499-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04499-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04499-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:04:22Z","timestamp":1770030262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04499-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4499"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04499-y","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by CET - Territorial Ethics Committee Lazio Area 1 (reference number: 6554, date of approval: November 24, 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"CC served as speaker, consultant and received travel reimbursement from Abiogen. She also served as consultant and in advisory board of Ascendis Pharma and IBSA and as speaker for Italfarmaco. The other authors have nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"55"}}